Sunesis Pharmaceuticals Announces Closing of $40 Million in Previously Announced Royalty and Debt Financings

Sunesis Pharmaceuticals, Inc.

today announced the closing of two previously disclosed financings. Royalty Pharma has invested $25.0 million under its royalty arrangement with Sunesis, and, in a separate transaction, a syndicate of lenders have funded the second tranche of $15.0 million under their $25.0 million loan facility with the company.